SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals informs about financial results

21 Jan 2013 Evaluate

Alembic Pharmaceuticals has informed about the financial results, results press release & a copy of the limited review report for the period ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

784.45 -4.30 (-0.55%)
12-May-2026 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1869.65
Dr. Reddys Lab 1277.00
Cipla 1298.20
Zydus Lifesciences 944.05
Lupin 2243.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×